Sitero expands Ash clinical AI across the full trial data lifecycle

Sitero on August 18, 2026, launched three new agentic workflows for Ash across study setup, data management and portfolio insights. The rollout is designed to speed clinical operations while keeping human review, audit trails and governed data controls in place.

Why it matters: - Sitero is pushing Ash beyond a single use case and into the full clinical data lifecycle, from study configuration to lock readiness and portfolio oversight. - The company is betting that a governed AI layer can shorten trial setup and data review timelines without giving up human oversight, auditability or GxP controls. - The new workflows are aimed at sponsors and clinical operations teams that need faster trial execution and earlier visibility into risk.

What happened: - Sitero, a clinical research organization and clinical technology company, announced the simultaneous release of three agentic workflows for Ash: Ash for Study Configuration, Ash for Data Management and Ash for Insights. - The launch covers study setup, continuous data review and portfolio-level visibility. - Clinical leaders can learn more and request a walkthrough at sitero.com/ash.

The details: - SiteroAI, the underlying clinical intelligence engine, continuously ingests and harmonizes data from EDC, IRT/RTSM, central and local labs, ePRO, safety databases and third-party vendor feeds into a single governed data layer. - Ash runs directly on SiteroAI, so workflows and recommendations use a complete, current and permission-aware view of study data. - The governance model includes human review at every decision gate, outputs grounded in study-specific source data, permission-aware access controls and a full audit trail for each action. - No Ash agentic workflow makes autonomous clinical, safety or quality decisions. - Ash for Study Configuration can take a protocol from upload to a fully configured live study in two weeks, versus months-long specification cycles in traditional approaches. - The workflow generates a structured study draft that includes the study tree, visits, forms, fields, codelists and edit checks from SiteroAI's protocol and standards libraries. - Teams review the draft, add comments and release the study build. - Ash for Study Configuration also manages the full study setup and change lifecycle. - Integrated eBinders keep annotated CRFs, edit check specs, data management plans and amendment histories organized, versioned and audit-ready in one place. - eSignature workflows let qualified team members review and sign off on specifications electronically. - When a protocol amendment or study change starts, Ash identifies downstream impact, routes updated specs for review and signature, and updates the eBinder. - Sitero says that process compresses what has historically been a weeks-long change management cycle into days. - Ash for Data Management delivered more than 180 data review program checks in about five weeks in an early deployment with a top-ten pharmaceutical company. - Sitero estimates the same work would take three to four months using traditional SAS-based methods, or about 75% longer. - The data management workflow includes continuous data review, query management and vendor reconciliation through two integrated capabilities. - DM Workbench gives data managers a single role-based workspace, with reviews auto-assigned by data type, therapeutic area and team structure. - Ash filters out irrelevant noise so team members see only the data issues that matter to them. - Clean Patient Tracker shows per-subject readiness status, open blockers and query history in one view. - Data issues surface as they occur instead of waiting for the next scheduled review. - Every check generates a logged audit-trail entry. - Ash for Insights provides study and portfolio-level dashboards with database lock forecasting. - Teams can track clean patient status, query trends and lock readiness continuously instead of waiting until lock time. - Portfolio visibility across multiple concurrent studies appears in a single view. - The platform gives clinical operations and leadership an always-current picture of trial health. - Ash uses a cloud-native architecture with a natural-language-native interface. - The platform includes GxP compliance support, data governance controls, security and data lifecycle management. - Ash is designed to work with existing sponsor systems, including EDC, RTSM and third-party data sources, through APIs and SDKs. - SiteroAI serves as the integration and harmonization layer. - Sitero's AI roadmap includes future capabilities in development: Ash for SDTM automation, Ash for Medical Monitoring and Ash for RBQM. - Sitero's broader business combines proprietary technology with clinical services for sponsors running clinical trials.

Between the lines: - The launch shows Sitero is positioning Ash as an operating layer for clinical development rather than a point solution. - The emphasis on human review, permission-aware access and audit trails suggests the company is trying to answer the main objection to AI in regulated trial environments: trust. - The data harmonization layer is the key differentiator here. Sitero is arguing that AI becomes more useful when it operates on unified study data instead of disconnected systems.

What's next: - Sitero is inviting clinical leaders to request walkthroughs of Ash and its agentic workflows. - The company says next-horizon capabilities in active development include SDTM automation, medical monitoring and RBQM. - Future releases will likely extend Ash further into downstream trial operations if the current workflows gain adoption.

The bottom line: - Sitero is trying to make Ash the AI control layer for clinical trials, with speed gains built around a governed, human-reviewed data foundation.